{"url":"https://lda.senate.gov/api/v1/filings/679b9ccf-e6c3-4dc4-8fd0-ff4eafb96c67/","filing_uuid":"679b9ccf-e6c3-4dc4-8fd0-ff4eafb96c67","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/679b9ccf-e6c3-4dc4-8fd0-ff4eafb96c67/print/","filing_document_content_type":"text/html","income":null,"expenses":"140000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Jonathan Kimball","dt_posted":"2026-04-20T13:06:59-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"100 College Road West","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Princeton","registrant_state":"NJ","registrant_zip":"08540","registrant":{"id":401108151,"url":"https://lda.senate.gov/api/v1/registrants/401108151/","house_registrant_id":56362,"name":"SANDOZ INC","description":null,"address_1":"100 College Road West","address_2":null,"address_3":null,"address_4":null,"city":"Princeton","state":"NJ","state_display":"New Jersey","zip":"08540","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JONATHAN KIMBALL","contact_telephone":"+1 202-641-5898","dt_updated":"2026-07-28T18:02:18.051435-04:00"},"client":{"id":58549,"url":"https://lda.senate.gov/api/v1/clients/58549/","client_id":58549,"name":"SANDOZ INC","general_description":"Pharmaceutical company","client_government_entity":null,"client_self_select":true,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2023-11-20"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Policies related to the ASP calculation in Medicare Part B Promoting a resilient pharmaceutical supply chain Policies related to serial patent litigation under the Hatch-Waxman Act. Issues related to increasing access to generic and biosimilar medications","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152571,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"BARNARD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153593,"prefix":null,"prefix_display":null,"first_name":"KATHLEEN","nickname":null,"middle_name":null,"last_name":"CALLANAN","suffix":null,"suffix_display":null},"covered_position":"Senior Legislative Assistant, Representative Mike Ross","new":true},{"lobbyist":{"id":151763,"prefix":null,"prefix_display":null,"first_name":"JONATHAN","nickname":null,"middle_name":null,"last_name":"KIMBALL","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":25,"name":"Defense, Dept of (DOD)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}